adamantane has been researched along with Glioma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annunziata, P; Cioni, C; Corelli, F; Marotta, G; Mugnaini, C; Tassi, M | 1 |
| De, L; Yong, Z; Yuan, T | 1 |
| Drummond, KJ; Kan, LK; Monif, M; O'Brien, TJ; Seneviratne, S; Williams, DA | 1 |
| Chang, YA; Fleischer, EB; Geisert, EE; Kang, GS; Miller, DD; Mohler, ML; Shea, KJ; Wagner, CE | 1 |
4 other study(ies) available for adamantane and Glioma
| Article | Year |
|---|---|
A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
Topics: Adamantane; Apoptosis; Cannabinoid Receptor Agonists; Cannabinoids; Cell Proliferation; Dose-Response Relationship, Drug; Glioma; Humans; Quinolones; Receptor, Cannabinoid, CB2; Transforming Growth Factor beta; Tumor Cells, Cultured | 2019 |
ST1926 inhibits glioma progression through regulating mitochondrial complex II.
Topics: Adamantane; Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cinnamates; Disease Progression; Electron Transport Complex II; Energy Metabolism; Enzyme Inhibitors; Glioma; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
Topics: Adamantane; Aminoquinolines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Microglia; Microscopy, Confocal; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Tumor Microenvironment | 2020 |
Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
Topics: Adamantane; Animals; Antigens, CD; Antineoplastic Agents; Antiviral Agents; Astrocytes; Boron Compounds; Crystallography, X-Ray; Dose-Response Relationship, Drug; Glioma; Hepacivirus; Membrane Proteins; Models, Molecular; Protein Binding; Rats; Structure-Activity Relationship; Tetraspanin 28; Tumor Cells, Cultured | 2003 |